Sanzone Virginia Ruth, VP and General Counsel, has demonstrated a consistent pattern of selling shares in ICU Medical Inc. (ICUI) over multiple years, with no recorded purchases in SEC filings. Her 28 reported transactions since 2024 exclusively involve dispositions, totaling $4.25 million in aggregate value. The activity shows concentrated selling in March of each year, likely tied to scheduled vesting events, with additional smaller sales in November 2025 and March 2024. Notably, her March 2026 transactions included four separate sales totaling $2.48 million, with the largest single transaction valued at $1.75 million on March 8.
The filings reveal a recurring cycle of equity compensation realization, with "F" coded transactions (indicating tax liability payments) consistently accompanied by zero-value "M" coded transfers (likely option exercises). Her most recent disposals on March 15, 2026—worth $112,887 and $396,427—followed similarly timed sales in prior years, including $128,818 and $249,725 in March 2025. While the November 2025 sale of $132,380 marked a departure from the March-centric pattern, the overall trend shows methodical monetization of equity awards rather than discretionary trading. All transactions relate exclusively to ICUI, where she serves as legal executive, with no diversification into other securities.
AI-assisted summary